Current versus lifetime depression, APOE variation, and their interaction on cognitive performance in younger and older adults

Psychosomatic Medicine

Volumn 77, Issue 5, 2015, Pages 480-492

  Luciano, Michelle ^a,b   Pujals, Ana Maria Fernandez ^a   Marioni, Riccardo E ^a,c,d   Campbell, Archie ^c   Hayward, Caroline ^a   MacIntyre, Donald J ^a   Porteous, David J ^a,c   McIntosh, Andrew M ^a   Deary, Ian J ^a,b  

^a UNIVERSITY OF EDINBURGH   (United Kingdom)

^b Division of Psychiatry Charles Bell House   (United Kingdom)

^c Medical Genetics Section   (United Kingdom)

^d UNIVERSITY OF QUEENSLAND   (Australia)

Author keywords

apolipoprotein E.; general health questionnaire; memory; processing speed; Structured Clinical Interview for DSM IV depression; verbal ability

Indexed keywords

APOLIPOPROTEIN E4;

ADULT; AGE DISTRIBUTION; AGED; ALLELE; ARTICLE; COGNITION; DEMOGRAPHY; DEPRESSION; DISEASE ASSOCIATION; FEMALE; GENETIC VARIABILITY; HUMAN; LIFETIME DEPRESSION; MAJOR CLINICAL STUDY; MALE; MEMORY; MIDDLE AGED; PRIORITY JOURNAL; VERY ELDERLY; YOUNG ADULT; ADOLESCENT; AGING; COGNITIVE DEFECT; GENETICS; PATHOPHYSIOLOGY; PHYSIOLOGY; SCOTLAND; TIME FACTOR;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; AGING; APOLIPOPROTEIN E4; COGNITION; COGNITION DISORDERS; DEPRESSIVE DISORDER; FEMALE; HUMANS; MALE; MIDDLE AGED; SCOTLAND; TIME FACTORS; YOUNG ADULT;

EID: 84930920327     PISSN: 00333174     EISSN: 15347796     Source Type: Journal    
DOI: 10.1097/PSY.0000000000000190     Document Type: Article

References (60)

1. McDermott LM, Ebmeier KP,. A meta-Analysis of depression severity and cognitive function. J Affect Disord 2009; 119: 1-8.
2. Rabbitt P, Donlan C, Watson P, McInnes L, Bent N,. Unique and interactive effects of depression, age, socioeconomic advantage, and gender on cognitive performance of normal healthy older people. Psychol Aging 1995; 10: 307-13.
3. Wisdom NM, Callahan JL, Hawkins KA,. The effects of apolipoprotein E on non-impaired cognitive functioning: a meta-Analysis. Neurobiol Aging 2011; 32: 63-74.
4. Payami H, Grimslid H, Oken B, Camicioli R, Sexton G, Dame A, Howieson D, Kaye J,. A prospective study of cognitive health in the elderly (Oregon Brain Aging Study): effects of family history and apolipoprotein E genotype. Am J Hum Genet 1997; 60: 948-56.
5. Brayne C, Harrington CR, Wischik CM, Huppert FA, Chi LY, Xuereb JH, O'Connor DW, Paykel ES,. Apolipoprotein E genotype in the prediction of cognitive decline and dementia in a prospectively studied elderly population. Dementia 1996; 7: 169-74.
6. Schiepers OJ, Harris SE, Gow AJ, Pattie A, Brett CE, Starr JM, Deary IJ,. APOE E4 status predicts age-related cognitive decline in the ninth decade: longitudinal follow-up of the Lothian Birth Cohort 1921. Mol Psychiatry 2012; 17: 315-24.
7. Corsentino EA, Sawyer K, Sachs-Ericsson N, Blazer DG,. Depressive symptoms moderate the influence of the apolipoprotein epsilon4 allele on cognitive decline in a sample of community dwelling older adults. Am J Geriatr Psychiatry 2009; 17: 155-65.
8. Rajan KB, Wilson RS, Skarupski KA, Mendes de Leon CF, Evans DA,. Gene-behavior interaction of depressive symptoms and the apolipoprotein E {varepsilon}4 allele on cognitive decline. Psychosom Med 2014; 76: 101-8.
9. Austin MP, Mitchell P, Goodwin GM,. Cognitive deficits in depression: possible implications for functional neuropathology. Br J Psychiatry 2001; 178: 200-6.
10. Castaneda AE, Tuulio-Henriksson A, Marttunen M, Suvisaari J, Lonnqvist J,. A review on cognitive impairments in depressive and anxiety disorders with a focus on young adults. J Affect Disord 2008; 106: 1-27.
11. Goodwin GM,. Neuropsychological and neuroimaging evidence for the involvement of the frontal lobes in depression. J Psychopharmacol 1997; 11: 115-22.
12. Pantzar A, Laukka EJ, Atti AR, Fastbom J, Fratiglioni L, Backman L,. Cognitive deficits in unipolar old-Age depression: a population-based study. Psychol Med 2014; 44: 937-47.
13. Hasselbalch BJ, Knorr U, Kessing LV,. Cognitive impairment in the remitted state of unipolar depressive disorder: a systematic review. J Affect Disord 2011; 134: 20-31.
14. Neu P, Bajbouj M, Schilling A, Godemann F, Berman RM, Schlattmann P,. Cognitive function over the treatment course of depression in middle-Aged patients: correlation with brain MRI signal hyperintensities. J Psychiatr Res 2005; 39: 129-35.
15. Reppermund S, Ising M, Lucae S, Zihl J,. Cognitive impairment in unipolar depression is persistent and non-specific: further evidence for the final common pathway disorder hypothesis. Psychol Med 2009; 39: 603-14.
16. Corder EH, Saunders AM, Strittmatter WJ, Schmechel DE, Gaskell PC, Small GW, Roses AD, Haines JL, Pericak-Vance MA,. Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families. Science 1993; 261: 921-3.
17. Savitz J, Solms M, Ramesar R,. Apolipoprotein E variants and cognition in healthy individuals: a critical opinion. Brain Res Rev 2006; 51: 125-35.
18. Lind J, Larsson A, Persson J, Ingvar M, Nilsson LG, Backman L, Adolfsson R, Cruts M, Sleegers K, Van Broeckhoven C, Nyberg L,. Reduced hippocampal volume in non-demented carriers of the apolipoprotein E epsilon4: relation to chronological age and recognition memory. Neurosci Lett 2006; 396: 23-7.
19. Steffens DC, McQuoid DR, Payne ME, Potter GG,. Change in hippocampal volume on magnetic resonance imaging and cognitive decline among older depressed and nondepressed subjects in the neurocognitive outcomes of depression in the elderly study. Am J Geriatr Psychiatry 2011; 19: 4-12.
20. Shu H, Yuan Y, Xie C, Bai F, You J, Li L, Li SJ, Zhang Z,. Imbalanced hippocampal functional networks associated with remitted geriatric depression and apolipoprotein E epsilon4 allele in nondemented elderly: a preliminary study. J Affect Disord 2014; 164: 5-13.
21. Niti M, Yap KB, Kua EH, Ng TP,. APOE-epsilon4, depressive symptoms, and cognitive decline in Chinese older adults: Singapore Longitudinal Aging Studies. J Gerontol A Biol Sci Med Sci 2009; 64: 306-11.
22. Pedersen CB, Mors O, Bertelsen A, Waltoft BL, Agerbo E, McGrath JJ, Mortensen PB, Eaton WW,. A comprehensive nationwide study of the incidence rate and lifetime risk for treated mental disorders. JAMA Psychiatry 2014; 71: 573-81.
23. Marioni RE, Campbell A, Generation Scotland, Hayward C, Porteous DJ, Deary IJ,. Differential effects of the APOE e4 allele on different domains of cognitive ability across the life-course. Eur J Hum Genet. In Press.
24. Smith BH, Campbell A, Linksted P, Fitzpatrick B, Jackson C, Kerr SM, Deary IJ, Macintyre DJ, Campbell H, McGilchrist M, Hocking LJ, Wisely L, Ford I, Lindsay RS, Morton R, Palmer CN, Dominiczak AF, Porteous DJ, Morris AD,. Cohort Profile: Generation Scotland: Scottish Family Health Study (GS:SFHS). The study, its participants and their potential for genetic research on health and illness. Int J Epidemiol 2013; 42: 689-700.
25. Kerr SM, Campbell A, Murphy L, Hayward C, Jackson C, Wain LV, Tobin MD, Dominiczak A, Morris A, Smith BH, Porteous DJ,. Pedigree and genotyping quality analyses of over 10,000 DNA samples from the Generation Scotland: Scottish Family Health Study. BMC Med Genet 2013; 14: 38.
26. Goldberg D,. General Health Questionnaire. Windsor: NFER Publishing Company; 1978.
27. Wechsler D,. WAIS-III Weschler Adult Intelligence Scale. San Antonio, TX: Psychological Corporation; 1997.
28. Wechsler D,. WMS-IIIUK Administration and Scoring Manual. London, UK: Psychological Corporation; 1998.
29. Lezak M,. Neuropsychological Testing. Oxford, UK.: Oxford University Press; 2004.
30. Raven JC, Court JH, Raven J,. Manual for Raven's Progressive Matrices and Vocabulary Scales. H. K. Lewis: London, UK: H. K. Lewis; 1977.
31. R Development Core Team. R: A Language and Environment for Statistical Computing. Vienna, Austria: R Foundation for Statistical Computing; 2008.
32. Butler DG, Cullis BR, Gilmour AR, Gogel BJ,. ASReml-R Reference Manual. Brisbane, Australia: Queensland Department of Primary Industries and Fisheries; 2009.
33. Krishnan KR, Tupler LA, Ritchie JC Jr, McDonald WM, Knight DL, Nemeroff CB, Carroll BJ,. Apolipoprotein E-epsilon 4 frequency in geriatric depression. Biol Psychiatry 1996; 40: 69-71.
34. Rigaud AS, Traykov L, Caputo L, Coste J, Latour F, Couderc R, Moulin F, Boller F, Forette F,. Association of the apolipoprotein E epsilon4 allele with late-onset depression. Neuroepidemiology 2001; 20: 268-72.
35. Yen YC, Rebok GW, Gallo JJ, Yang MJ, Lung FW, Shih CH,. ApoE4 allele is associated with late-life depression: a population-based study. Am J Geriatr Psychiatry 2007; 15: 858-68.
36. Cervilla J, Prince M, Joels S, Russ C, Lovestone S,. Genes related to vascular disease (APOE, VLDL-R, DCP-1) and other vascular factors in late-life depression. Am J Geriatr Psychiatry 2004; 12: 202-10.
37. Forsell Y, Corder EH, Basun H, Lannfelt L, Viitanen M, Winblad B,. Depression and dementia in relation to apolipoprotein E polymorphism in a population sample age 75+. Biol Psychiatry 1997; 42: 898-903.
38. Locke DE, Dueck AC, Stonnington CM, Knopman DS, Geda YE, Caselli RJ,. Depressive symptoms in healthy apolipoprotein E epsilon4 carriers and noncarriers: a longitudinal study. J Clin Psychiatry 2013; 74: 1256-61.
39. Parker G,. Defining melancholia: the primacy of psychomotor disturbance. Acta Psychiatr Scand Suppl 2007: 21-30.
40. Ballmaier M, Toga AW, Blanton RE, Sowell ER, Lavretsky H, Peterson J, Pham D, Kumar A,. Anterior cingulate, gyrus rectus, and orbitofrontal abnormalities in elderly depressed patients: an MRI-based parcellation of the prefrontal cortex. Am J Psychiatry 2004; 161: 99-108.
41. Shimada H, Park H, Makizako H, Doi T, Lee S, Suzuki T,. Depressive symptoms and cognitive performance in older adults. J Psychiatr Res 2014; 57: 149-56.
42. Ayotte BJ, Potter GG, Williams HT, Steffens DC, Bosworth HB,. The moderating role of personality factors in the relationship between depression and neuropsychological functioning among older adults. Int J Geriatr Psychiatry 2009; 24: 1010-9.
43. Glahn DC, Almasy L, Barguil M, Hare E, Peralta JM, Kent JW Jr, Dassori A, Contreras J, Pacheco A, Lanzagorta N, Nicolini H, Raventos H, Escamilla MA,. Neurocognitive endophenotypes for bipolar disorder identified in multiplex multigenerational families. Arch Gen Psychiatry 2010; 67: 168-77.
44. Kluger A, Goldberg E,. IQ patterns in affective disorder, lateralized and diffuse brain damage. J Clin Exp Neuropsychol 1990; 12: 182-94.
45. Mason CF,. Pre-illness intelligence of mental hospital patients. J Consult Psychol 1956; 20: 297-300.
46. Robertson G, Taylor PJ,. Some cognitive correlates of affective disorders. Psychol Med 1985; 15: 297-309.
47. Gale CR, Batty GD, McIntosh AM, Porteous DJ, Deary IJ, Rasmussen F,. Is bipolar disorder more common in highly intelligent people? A cohort study of a million men. Mol Psychiatry 2013; 18: 190-4.
48. Fergusson DM, Horwood LJ, Ridder EM,. Show me the child at seven II: childhood intelligence and later outcomes in adolescence and young adulthood. J Child Psychol Psychiatry 2005; 46: 850-8.
49. Gale CR, Deary IJ, Boyle SH, Barefoot J, Mortensen LH, Batty GD,. Cognitive ability in early adulthood and risk of 5 specific psychiatric disorders in middle age: the Vietnam experience study. Arch Gen Psychiatry 2008; 65: 1410-8.
50. Schaie KW,. The course of adult intellectual development. Am Psychol 1994; 49: 304-13.
51. Deary IJ, Whiteman MC, Starr JM, Whalley LJ, Fox HC,. The impact of childhood intelligence on later life: following up the Scottish mental surveys of 1932 and 1947. J Pers Soc Psychol 2004; 86: 130-47.
52. Gow AJ, Johnson W, Pattie A, Whiteman MC, Starr J, Deary IJ,. Mental ability in childhood and cognitive aging. Gerontology 2008; 54: 177-86.
53. Richards M, Shipley B, Fuhrer R, Wadsworth ME,. Cognitive ability in childhood and cognitive decline in mid-life: longitudinal birth cohort study. BMJ 2004; 328: 552.
54. Christiansen P, Larsson HB, Thomsen C, Wieslander SB, Henriksen O,. Age dependent white matter lesions and brain volume changes in healthy volunteers. Acta Radiol 1994; 35: 117-22.
55. Hedden T, Gabrieli JD,. Insights into the ageing mind: a view from cognitive neuroscience. Nat Rev Neurosci 2004; 5: 87-96.
56. Miners JS, Jones R, Love S,. Differential changes in Abeta42 and Abeta40 with age. J Alzheimers Dis 2014; 40: 727-35.
57. Licastro F, Candore G, Lio D, Porcellini E, Colonna-Romano G, Franceschi C, Caruso C,. Innate immunity and inflammation in ageing: a key for understanding age-related diseases. Immun Ageing 2005; 2: 8.
58. Diniz BS, Sibille E, Ding Y, Tseng G, Aizenstein HJ, Lotrich F, Becker JT, Lopez OL, Lotze MT, Klunk WE, Reynolds CF, Butters MA,. Plasma biosignature and brain pathology related to persistent cognitive impairment in late-life depression. Mol Psychiatry 2014.
59. Holtzman DM, Morris JC, Goate AM,. Alzheimer's disease: the challenge of the second century. Sci Transl Med 2011; 3: 77sr1.
60. Luciano M,. Apolipoprotein E and depressive symptoms: shared or independent routes to age-related cognitive decline? Psychosom Med 2014; 76: 98-100.